JUPITER, Fla. and DHAKA, Bangladesh, June 21, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”,…
MUNICH, Germany, June 21, 2023 (GLOBE NEWSWIRE) — HMNC Brain Health (“HMNC” or the “company”),…
WIB-CT How to Build a Better Board Erika Smith (left to right), CEO ReNetX, moderated…
Research grants from U.S. Department of Defense (DoD) and National Cancer Institute’s Research Project Grant…
BERKELEY HEIGHTS, N.J., June 21, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical…
Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using…
Comprehensively reversed disease progression symptoms in a CMT mice model Selected for an oral presentation…
WAKEFIELD, MA, June 21, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the…
CARSON CITY, Nev., June 21, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
SAN JOSE, Calif., June 21, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
FARMINGTON HILLS, Mich., June 21, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a…
Early-Stage Candidates for Primary Hyperparathyroidism and Thyroid Eye Disease Also Featured Crinetics’ Founder & CEO, Scott…
Evaluating safety and efficacy of combining AB-729, VTP-300, nucleos(t)ide analogues and nivolumab (Opdivo®) WARMINSTER, Pa.,…
CINCINNATI, June 21, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
MELBOURNE, Australia and SAN FRANCISCO, June 21, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH,…
Change in Total Motor Score June 2023 Webcast Presentation Neurofilament Light Chain (Nfl) percentage change…
With millions of Americans experiencing mental health symptoms, 23andMe+ members now have exclusive access to…
Company is well-positioned to advance robust clinical-stage CNS pipeline, following oversubscribed Series B financing earlier…
Jabil’s J312-S and J322-S purpose-built servers are powered by 4th Gen Intel® Xeon® Scalable processors…